Li Yang, Shi Yiqin, Zhu Bowen, Chen Yafei, Shen Bo, Zhao Shuan, Song Nana, Fang Yi, Ding Xiaoqiang
Department of Nephrology, Zhongshan Hospital, Fudan University, Shanghai, China.
Shanghai Clinical Research Center for Kidney Disease, Shanghai, China.
BMC Public Health. 2025 May 7;25(1):1685. doi: 10.1186/s12889-025-22924-9.
Chronic kidney disease (CKD) is a global public health problem. This study aimed to evaluate the complex relationship of CKD and cardiovascular disease (CVD) risk with mortality in different age groups and the mediation effect of CVD risk among Chinese adults.
A total of 7533 participants from the 2009 wave of China Health and Nutrition Survey (CHNS) cohort were included in this study and followed up to 2015. CKD was defined as the estimated glomerular filtration rate (eGFR) < 60 mL/min/1.73m. Framingham risk score (FRS) was used to assess CVD risk. The interaction, joint association of CVD risk and CKD on mortality, and subsequent mediation effect were evaluated using multivariable Cox regression.
CHNS cohort recorded 266 deaths over a mean follow-up time of 5.04 years. The all-mortality rates among adults with CKD and high CVD risk were significantly higher than healthy controls (22.48 and 21.30 per 1000 person-years). After adjusting for covariates of age, gender, BMI, hypertension, diabetes, hyperuricemia, smoking status, and alcohol consumption, the adjusted hazard ratios (aHR) of CKD and high CVD risk were 1.70 (95% CI 1.27-2.28) and 1.62 (95%CI 1.26-2.09), respectively. Joint effect analysis revealed that mortality hazard was highest in CKD patients with high CVD risk (aHR = 3.15, 95% CI 1.92-5.16). Mediation analysis showed that significant partial mediation by SBP and fasting glucose, accounting for 19.2% (p < 0.001) and 3.52% (p = 0.012) of the total effect of CKD on mortality.
Comprehensive strategies including lifestyle modifications, diet restrictions, and cardio-nephrology multidisciplinary treatment for mitigating CVD risk in CKD patients should focus on middle-aged people and early disease detection.
慢性肾脏病(CKD)是一个全球性的公共卫生问题。本研究旨在评估不同年龄组中CKD与心血管疾病(CVD)风险和死亡率之间的复杂关系,以及CVD风险在中国成年人中的中介作用。
本研究纳入了中国健康与营养调查(CHNS)队列2009年调查周期中的7533名参与者,并随访至2015年。CKD定义为估计肾小球滤过率(eGFR)<60 mL/min/1.73m²。采用弗雷明汉风险评分(FRS)评估CVD风险。使用多变量Cox回归评估CVD风险与CKD对死亡率的交互作用、联合关联以及随后的中介作用。
CHNS队列在平均5.04年的随访期内记录了266例死亡。CKD患者和CVD高风险成年人的全因死亡率显著高于健康对照组(每1000人年分别为22.48和21.30)。在调整年龄、性别、体重指数、高血压、糖尿病、高尿酸血症、吸烟状况和饮酒等协变量后,CKD和CVD高风险的调整后风险比(aHR)分别为1.70(95%CI 1.27 - 2.28)和1.62(95%CI 1.26 - 2.09)。联合效应分析显示,CVD高风险的CKD患者死亡风险最高(aHR = 3.15,95%CI 1.92 - 5.16)。中介分析表明,收缩压和空腹血糖存在显著的部分中介作用,分别占CKD对死亡率总效应的19.2%(p < 0.001)和3.52%(p = 0.012)。
包括生活方式改变、饮食限制以及心脏肾脏病多学科治疗在内的综合策略,以减轻CKD患者的CVD风险,应关注中年人并尽早进行疾病检测。